BRINZVIEW (Brinzolamide (1% w/v))

BRINZVIEW EYE DROP is utilized for managing elevated intraocular pressure in individuals diagnosed with glaucoma or experiencing ocular hypertension. Elevated pressure within the eye can lead to vision impairment, making effective treatment essential. The active formulation of BRINZVIEW EYE DROP functions by reducing the production of fluid within the eye, helping to maintain a healthier pressure level. Prior to the initial use, it is crucial to ensure that the seal on the bottle is intact. Proper hand hygiene is necessary before administration, and it is recommended to shake the bottle thoroughly each time before application. For those who wear contact lenses, it is important to remove them prior to applying the drops and to wait at least 15 minutes before reinserting them. It is essential to follow your healthcare provider’s guidance and not discontinue the medication without consultation, as failure to do so may result in uncontrolled eye pressure, potentially leading to further vision complications. The most frequently reported side effects include temporary blurred vision and a bitter taste in the mouth. Users may also occasionally experience broader effects such as shortness of breath, dizziness, fatigue, or irregular heartbeat. If any visual disturbances occur, it is advised to refrain from driving until clarity is restored.